Anticoagulant effect of low molecular weight fractions derived from a chemically modified heparin.
Nagasawa
K
K
School of Pharmaceutical Sciences, Kitasato University, Tokyo, Japan.
Uchiyama
H
H
Yajima
D
D
D001777:Blood Coagulation / Q000187:drug effects; D065427:Factor Xa Inhibitors; D006495:Heparin, Low-Molecular-Weight / Q000302:isolation & purification / Q000494:pharmacology*; D006801:Humans; D010314:Partial Thromboplastin Time
D065427:Factor Xa Inhibitors; D006495:Heparin, Low-Molecular-Weight